Literature DB >> 15316659

Infection of cultured intestinal epithelial cells with severe acute respiratory syndrome coronavirus.

J Cinatl1, G Hoever, B Morgenstern, W Preiser, J-U Vogel, W-K Hofmann, G Bauer, M Michaelis, H F Rabenau, H W Doerr.   

Abstract

To identify a model for the study of intestinal pathogenesis of severe acute respiratory syndrome (SARS) we tested the sensitivity of six human intestinal epithelial cell lines to infection with SARS coronavirus (SARS-CoV). In permissive cell lines, effects of SARS-CoV on cellular gene expression were analysed using high-density oligonucleotide arrays. Caco-2 and CL-14 cell lines were found to be highly permissive to SARS-CoV, due to the presence of angiotensin-converting enzyme 2 as a functional receptor. In both cell lines, SARS-CoV infection deregulated expression of cellular genes which may be important for the intestinal pathogenesis of SARS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15316659      PMCID: PMC7079841          DOI: 10.1007/s00018-004-4222-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  37 in total

Review 1.  Mechanisms of severe acute respiratory syndrome pathogenesis and innate immunomodulation.

Authors:  Matthew Frieman; Ralph Baric
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

2.  Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by severe acute respiratory syndrome coronavirus and human coronavirus 229E.

Authors:  Bone S F Tang; Kwok-Hung Chan; Vincent C C Cheng; Patrick C Y Woo; Susanna K P Lau; Clarence C K Lam; Tsun-Leung Chan; Alan K L Wu; Ivan F N Hung; Suet-Yi Leung; Kwok-Yung Yuen
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

3.  Reverse genetic characterization of the natural genomic deletion in SARS-Coronavirus strain Frankfurt-1 open reading frame 7b reveals an attenuating function of the 7b protein in-vitro and in-vivo.

Authors:  Susanne Pfefferle; Verena Krähling; Vanessa Ditt; Klaus Grywna; Elke Mühlberger; Christian Drosten
Journal:  Virol J       Date:  2009-08-24       Impact factor: 4.099

4.  Unraveling the complexities of the interferon response during SARS-CoV infection.

Authors:  Anna de Lang; Tracey Baas; Saskia L Smits; Michael G Katze; Albert Dme Osterhaus; Bart L Haagmans
Journal:  Future Virol       Date:  2009-01-01       Impact factor: 1.831

5.  Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling.

Authors:  Dirk Holzinger; Carl Jorns; Silke Stertz; Stéphanie Boisson-Dupuis; Robert Thimme; Manfred Weidmann; Jean-Laurent Casanova; Otto Haller; Georg Kochs
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

6.  The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies.

Authors:  Stefanie Gierer; Stephanie Bertram; Franziska Kaup; Florian Wrensch; Adeline Heurich; Annika Krämer-Kühl; Kathrin Welsch; Michael Winkler; Benjamin Meyer; Christian Drosten; Ulf Dittmer; Thomas von Hahn; Graham Simmons; Heike Hofmann; Stefan Pöhlmann
Journal:  J Virol       Date:  2013-03-06       Impact factor: 5.103

Review 7.  Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection.

Authors:  Vincent C C Cheng; Susanna K P Lau; Patrick C Y Woo; Kwok Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

8.  Identifying COVID-19-Specific Transcriptomic Biomarkers with Machine Learning Methods.

Authors:  Lei Chen; Zhandong Li; Tao Zeng; Yu-Hang Zhang; KaiYan Feng; Tao Huang; Yu-Dong Cai
Journal:  Biomed Res Int       Date:  2021-07-06       Impact factor: 3.411

9.  Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection.

Authors:  Tomoki Yoshikawa; Terence E Hill; Naoko Yoshikawa; Vsevolod L Popov; Cristi L Galindo; Harold R Garner; C J Peters; Chien-Te Kent Tseng
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

10.  A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry.

Authors:  Yanwen Chen; Travis B Lear; John W Evankovich; Mads B Larsen; Bo Lin; Irene Alfaras; Jason R Kennerdell; Laura Salminen; Daniel P Camarco; Karina C Lockwood; Ferhan Tuncer; Jie Liu; Michael M Myerburg; John F McDyer; Yuan Liu; Toren Finkel; Bill B Chen
Journal:  Nat Commun       Date:  2021-06-23       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.